TSP Capital Management Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $784K | Hold |
27,500
| – | – | 0.2% | 40 |
|
|
2026
Q2 | $662K | Buy |
+27,500
| New | +$719K | 0.16% | 41 |
|
|
2026
Q1 | – | Hold |
0
| – | – | – | 40 |
|
|
2025
Q4 | – | Sell |
-44,100
| Closed | -$1.11M | – | 40 |
|
|
2025
Q3 | $1.12M | Buy |
+44,100
| New | +$1.09M | 0.3% | 37 |
|
|
2025
Q2 | – | Sell |
-44,100
| Closed | -$1.03M | – | 35 |
|
|
2025
Q1 | $1.12M | Sell |
44,100
-600
| -1% | -$15.7K | 0.37% | 37 |
|
|
2024
Q4 | $1.19M | Hold |
44,700
| – | – | 0.4% | 37 |
|
|
2024
Q3 | $1.29M | Hold |
44,700
| – | – | 0.4% | 37 |
|
|
2024
Q2 | $1.25M | Hold |
44,700
| – | – | 0.39% | 37 |
|
|
2024
Q1 | $1.24M | Hold |
44,700
| – | – | 0.4% | 38 |
|
|
2023
Q4 | $1.29M | Sell |
44,700
-40
| -0.1% | -$1.21K | 0.45% | 36 |
|
|
2023
Q3 | $1.48M | Sell |
44,740
-3,000
| -6% | -$106K | 0.57% | 32 |
|
|
2023
Q2 | $1.75M | Sell |
47,740
-1,640
| -3% | -$63.8K | 0.63% | 33 |
|
|
2023
Q1 | $2.01M | Sell |
49,380
-1,700
| -3% | -$73.4K | 0.73% | 33 |
|
|
2022
Q4 | $2.62M | Buy |
+51,080
| New | +$2.45M | 0.98% | 28 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 29 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 28 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 26 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 26 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 30 |
|
|
2021
Q2 | – | Sell |
-51,080
| Closed | -$1.99M | – | 33 |
|
|
2021
Q1 | $1.85M | Sell |
51,080
-960
| -2% | -$34.1K | 0.65% | 33 |
|
|
2020
Q4 | $1.92M | Buy |
+52,040
| New | +$1.91M | 0.68% | 28 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 28 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 31 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 28 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 28 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 26 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 25 |
|
|
2019
Q1 | – | Sell |
-57,313
| Closed | -$2.3M | – | 26 |
|
|
2018
Q4 | $2.37M | Buy |
+57,313
| New | +$2.38M | 1.33% | 28 |
|
|
2018
Q3 | – | Sell |
-59,843
| Closed | -$2.3M | – | 27 |
|
|
2018
Q2 | $2.06M | Sell |
59,843
-1,054
| -2% | -$36K | 1.06% | 29 |
|
|
2018
Q1 | $2.05M | Sell |
60,897
-2,055
| -3% | -$70.6K | 0.98% | 31 |
|
|
2017
Q4 | $2.16M | Sell |
62,952
-527
| -0.8% | -$18K | 0.98% | 29 |
|
|
2017
Q3 | $2.15M | Buy |
+63,479
| New | +$2.04M | 1.03% | 30 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 31 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 31 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 33 |
|
|
2016
Q3 | – | Sell |
-65,324
| Closed | -$2.18M | – | 29 |
|
|
2016
Q2 | $2.18M | Sell |
65,324
-685
| -1% | -$21.9K | 1.13% | 28 |
|
|
2016
Q1 | $1.86M | Sell |
66,009
-2,797
| -4% | -$79.9K | 1.02% | 30 |
|
|
2015
Q4 | $2.11M | Sell |
68,806
-685
| -1% | -$21.5K | 1.13% | 28 |
|
|
2015
Q3 | $2.07M | Sell |
69,491
-6,851
| -9% | -$220K | 1.16% | 26 |
|
|
2015
Q2 | $2.43M | Buy |
+76,342
| New | +$2.49M | 1.13% | 29 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 27 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 29 |
|
|
2014
Q3 | – | Sell |
-86,461
| Closed | -$2.43M | – | 30 |
|
|
2014
Q2 | $2.44M | Buy |
+86,461
| New | +$2.46M | 1.06% | 29 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 26 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 29 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 30 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 28 |
|
Other funds holding PFE
TSP Capital Management Group's PFE Position: Q3 2026 in Review
TSP Capital Management Group held its Pfizer (PFE) position steady in Q3 2026 at 27,500 shares worth $784K. The position accounts for 0.2% of the portfolio, ranked #40.
TSP Capital Management Group first reported a position in PFE in Q2 2014 and has held it in 26 quarters since. The position peaked at $2.62M in Q4 2022. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- TSP Capital Management Group held 27,500 shares of Pfizer worth $784K as of Q3 2026.
- TSP Capital Management Group left its Pfizer share count unchanged in Q3 2026.
- Pfizer made up 0.2% of TSP Capital Management Group's portfolio in Q3 2026, its #40 holding.
- TSP Capital Management Group first reported a position in Pfizer in Q2 2014 and has held it in 26 quarters since.
- TSP Capital Management Group's Pfizer position peaked at $2.62M in Q4 2022.
- 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on TSP Capital Management Group's 13F filing for Q3 2026, filed 15 Oct 2026.